Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Other Non Operating Income (2016 - 2020)

Historic Other Non Operating Income for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to $218000.0.

  • Larimar Therapeutics' Other Non Operating Income rose 84782.61% to $218000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $220000.0, marking a year-over-year increase of 24569.54%. This contributed to the annual value of $25000.0 for FY2019, which is 11054.85% up from last year.
  • Larimar Therapeutics' Other Non Operating Income amounted to $218000.0 in Q1 2020, which was up 84782.61% from $57000.0 recorded in Q4 2019.
  • Larimar Therapeutics' Other Non Operating Income's 5-year high stood at $218000.0 during Q1 2020, with a 5-year trough of -$97000.0 in Q4 2016.
  • In the last 5 years, Larimar Therapeutics' Other Non Operating Income had a median value of -$5000.0 in 2017 and averaged $7529.4.
  • As far as peak fluctuations go, Larimar Therapeutics' Other Non Operating Income plummeted by 137500.0% in 2016, and later skyrocketed by 84782.61% in 2020.
  • Quarter analysis of 5 years shows Larimar Therapeutics' Other Non Operating Income stood at -$97000.0 in 2016, then skyrocketed by 125.77% to $25000.0 in 2017, then plummeted by 320.0% to -$55000.0 in 2018, then skyrocketed by 203.64% to $57000.0 in 2019, then surged by 282.46% to $218000.0 in 2020.
  • Its last three reported values are $218000.0 in Q1 2020, $57000.0 for Q4 2019, and -$33000.0 during Q3 2019.